Somatosensory evoked fields predict response to vagus nerve stimulation.

Journal: NeuroImage. Clinical
PMID:

Abstract

There is an unmet need to develop robust predictive algorithms to preoperatively identify pediatric epilepsy patients who will respond to vagus nerve stimulation (VNS). Given the similarity in the neural circuitry between vagus and median nerve afferent projections to the primary somatosensory cortex, the current study hypothesized that median nerve somatosensory evoked field(s) (SEFs) could be used to predict seizure response to VNS. Retrospective data from forty-eight pediatric patients who underwent VNS at two different institutions were used in this study. Thirty-six patients ("Discovery Cohort") underwent preoperative electrical median nerve stimulation during magnetoencephalography (MEG) recordings and 12 patients ("Validation Cohort") underwent preoperative pneumatic stimulation during MEG. SEFs and their spatial deviation, waveform amplitude and latency, and event-related connectivity were calculated for all patients. A support vector machine (SVM) classifier was trained on the Discovery Cohort to differentiate responders from non-responders based on these input features and tested on the Validation Cohort by comparing the model-predicted response to VNS to the known response. We found that responders to VNS had significantly more widespread SEF localization and greater functional connectivity within limbic and sensorimotor networks in response to median nerve stimulation. No difference in SEF amplitude or latencies was observed between the two cohorts. The SVM classifier demonstrated 88.9% accuracy (0.93 area under the receiver operator characteristics curve) on cross-validation, which decreased to 67% in the Validation cohort. By leveraging overlapping neural circuitry, we found that median nerve SEF characteristics and functional connectivity could identify responders to VNS.

Authors

  • Karim Mithani
    The Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Simeon M Wong
    Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
  • Mirriam Mikhail
    The Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Haatef Pourmotabbed
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA; Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.
  • Elizabeth Pang
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Roy Sharma
    Division of Neurology, Hospital for Sick Children, Toronto, Canada.
  • Ivanna Yau
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Ayako Ochi
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hiroshi Otsubo
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • O Carter Snead
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Elizabeth Donner
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cristina Go
    Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Elysa Widjaja
    Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Abbas Babajani-Feremi
    Department of Pediatrics, Division of Clinical Neurosciences, University of Tennessee Health Science Center, Memphis, TN, USA; Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN, USA; Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: ababajan@uthsc.edu.
  • George M Ibrahim
    Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.